Cargando…
Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options
Maturity-Onset Diabetes of the Young (MODY) is a rare form of diabetes which affects between 1% and 5% of diagnosed diabetes cases. Clinical characterizations of MODY include onset of diabetes at an early age (before the age of 30), autosomal dominant inheritance pattern, impaired glucose-induced se...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697644/ https://www.ncbi.nlm.nih.gov/pubmed/36573710 http://dx.doi.org/10.3390/jpm12111762 |
_version_ | 1784838617501270016 |
---|---|
author | Younis, Hazar Ha, Se Eun Jorgensen, Brian G. Verma, Arushi Ro, Seungil |
author_facet | Younis, Hazar Ha, Se Eun Jorgensen, Brian G. Verma, Arushi Ro, Seungil |
author_sort | Younis, Hazar |
collection | PubMed |
description | Maturity-Onset Diabetes of the Young (MODY) is a rare form of diabetes which affects between 1% and 5% of diagnosed diabetes cases. Clinical characterizations of MODY include onset of diabetes at an early age (before the age of 30), autosomal dominant inheritance pattern, impaired glucose-induced secretion of insulin, and hyperglycemia. Presently, 14 MODY subtypes have been identified. Within these subtypes are several mutations which contribute to the different MODY phenotypes. Despite the identification of these 14 subtypes, MODY is often misdiagnosed as type 1 or type 2 diabetes mellitus due to an overlap in clinical features, high cost and limited availability of genetic testing, and unfamiliarity with MODY outside of the medical profession. The primary aim of this review is to investigate the genetic characterization of the MODY subtypes. Additionally, this review will elucidate the link between the genetics, function, and clinical manifestations of MODY in each of the 14 subtypes. In providing this knowledge, we hope to assist in the accurate diagnosis of MODY patients and, subsequently, in ensuring they receive appropriate treatment. |
format | Online Article Text |
id | pubmed-9697644 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96976442022-11-26 Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options Younis, Hazar Ha, Se Eun Jorgensen, Brian G. Verma, Arushi Ro, Seungil J Pers Med Review Maturity-Onset Diabetes of the Young (MODY) is a rare form of diabetes which affects between 1% and 5% of diagnosed diabetes cases. Clinical characterizations of MODY include onset of diabetes at an early age (before the age of 30), autosomal dominant inheritance pattern, impaired glucose-induced secretion of insulin, and hyperglycemia. Presently, 14 MODY subtypes have been identified. Within these subtypes are several mutations which contribute to the different MODY phenotypes. Despite the identification of these 14 subtypes, MODY is often misdiagnosed as type 1 or type 2 diabetes mellitus due to an overlap in clinical features, high cost and limited availability of genetic testing, and unfamiliarity with MODY outside of the medical profession. The primary aim of this review is to investigate the genetic characterization of the MODY subtypes. Additionally, this review will elucidate the link between the genetics, function, and clinical manifestations of MODY in each of the 14 subtypes. In providing this knowledge, we hope to assist in the accurate diagnosis of MODY patients and, subsequently, in ensuring they receive appropriate treatment. MDPI 2022-10-25 /pmc/articles/PMC9697644/ /pubmed/36573710 http://dx.doi.org/10.3390/jpm12111762 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Younis, Hazar Ha, Se Eun Jorgensen, Brian G. Verma, Arushi Ro, Seungil Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options |
title | Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options |
title_full | Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options |
title_fullStr | Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options |
title_full_unstemmed | Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options |
title_short | Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options |
title_sort | maturity-onset diabetes of the young: mutations, physiological consequences, and treatment options |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697644/ https://www.ncbi.nlm.nih.gov/pubmed/36573710 http://dx.doi.org/10.3390/jpm12111762 |
work_keys_str_mv | AT younishazar maturityonsetdiabetesoftheyoungmutationsphysiologicalconsequencesandtreatmentoptions AT haseeun maturityonsetdiabetesoftheyoungmutationsphysiologicalconsequencesandtreatmentoptions AT jorgensenbriang maturityonsetdiabetesoftheyoungmutationsphysiologicalconsequencesandtreatmentoptions AT vermaarushi maturityonsetdiabetesoftheyoungmutationsphysiologicalconsequencesandtreatmentoptions AT roseungil maturityonsetdiabetesoftheyoungmutationsphysiologicalconsequencesandtreatmentoptions |